Mukka Proteins IPO: Subscriptions Open Today, GMP Hints Premium Listing; Check Dates, Status And More

Mukka Proteins IPO opens for subscription today, February 29, with a goal of raising Rs 224 crores. The company had already made waves by securing Rs 67.20 crores from anchor investors on February 28, a day before the subscription window officially opened. Here's everything you need to know about this promising IPO that's making waves in the financial market.

Investors have a window from today until Monday, March 4, to subscribe to Mukka Proteins IPO. The anchor investor round, held on February 28, saw the company allocate 2,39,99,565 equity shares, raising Rs 67.20 crores.

Mukka Proteins IPO has a price band set at Rs 26 to Rs 28 per equity share with a face value of Re 1. The lot size for this IPO is 535 equity shares, and investors can bid in multiples of 535 equity shares thereafter. This structure aims to make the IPO accessible to a broad spectrum of investors.

Mukka Proteins IPO has reserved shares for different investor categories. Notably, up to 50% of the shares are reserved for Qualified Institutional Buyers (QIB), a minimum of 15% for Non-Institutional Investors (NII), and at least 35% for retail investors. This allocation strategy aims to cater to the interests of both institutional and retail participants.

Mukka Proteins Ltd is in the business of manufacturing and selling fish meal, fish oil, and fish soluble paste-essential components in aqua feed, poultry feed, and pet food. With a focus on sustainability, the company plays a crucial role in supporting the production of feed for fish, prawns, poultry, dogs, and cats.

The company's three promoter directors, Kalandan Mohammed Haris, Kalandan Mohammed Arif, and Kalandan Mohammed Althaf, actively contribute to the business, bringing a hands-on approach to its operations.

Comparing Mukka Proteins with its listed peers, such as Avanti Feeds Ltd, Godrej Agrovet Ltd, Zeal Aqua Ltd, and Waterbase Ltd, the company holds its ground. As of the last financial year ending March 31, 2023, Mukka Proteins reported an 84.07% growth in Profit After Tax (PAT) and a substantial 52.52% increase in revenue.

The IPO, valued at Rs 224 crores, consists entirely of a fresh issue of 8,00,00,000 equity shares with a face value of Re 1. The net proceeds from the IPO will be utilized for various purposes, as outlined in the red herring prospectus (RHP). These include funding general corporate purposes, investment in their associate company, Ento Proteins Private Limited, supporting working capital requirements, and overall business expansion.

Cameo Corporate Services Limited has been appointed as the registrar for Mukka Proteins IPO, while Fedex Securities Pvt Ltd is the book running lead manager, overseeing the smooth execution of the IPO process.

The Grey Market Premium (GMP) for Mukka Proteins IPO currently stands at +15, indicating a premium of Rs 15 in the grey market. This suggests a positive sentiment among investors, willing to pay more than the issue price.

According to the latest data, the GMP has been on an upward trend over the last 24 sessions, with the lowest being Rs 0 and the highest reaching Rs 17. This positive movement in the grey market bodes well for a strong listing.

As Mukka Proteins IPO enters the subscription phase, all eyes are on the market response and the potential for a robust listing. With a focus on sustainability, impressive financials, and a clear plan for fund utilization, Mukka Proteins is poised to make an entry on the stock exchanges.